On a July morning in Palo Alto, neuroscientist fellows lead my daughter and me to a windowless room with corporate carpet and tabletop computer monitors. The fellows fit us with near infra-red ...

Add Yahoo as a preferred source to see more of our stories on Google. For many people with fragile X, the mutated gene that causes symptoms is active rather than silenced. Thom Leach/Science Photo ...

Fragile X syndrome (FXS) and autism spectrum disorder (ASD) sometimes occur together. While FXS is a known genetic cause of ASD, not everyone who receives an FXS diagnosis is autistic, and not all ...

They called him “the singing baby.” As a newborn, Maxwell Wheeler would lie in his crib, whistling shrilly as he breathed in and out. For Cari and Andrew Wheeler of Madera Ranchos, Calif., it was one ...

Fragile X syndrome, the most common form of inherited intellectual disability, may be unfolding in brain cells even before birth, despite typically going undiagnosed until age 3 or later. A new study ...

COLUMBIA, S.C. (WIS) - Families and advocates gathered at the South Carolina State House Friday to bring awareness to Fragile X Syndrome. Fragile X Syndrome is a genetic disorder that affects the ...

Scientists have created a new therapeutic approach for testing fragile X syndrome, which is the most common genetic cause of autism spectrum disorder (ASD). This method aims to alter a type of neural ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted orphan drug designation to a small molecule therapeutic for individuals with Fragile X ...

Mutations in FMR1, the gene encoding fragile X messenger ribonucleoprotein 1 (FMRP), located at Xq27.3 and discovered in 1991, are the leading single-gene causes of autism and intellectual disability.

For 22 years, Jason Mazzola's life was defined by Fragile X, a genetic condition that often causes autism and intellectual disability. Jason, who is 24 now, needed constant supervision. He had ...

Servier has agreed to acquire Medicxi company Kaerus Bioscience's potential Fragile X syndrome (FXS) treatment, KER-0193. Servier will pay Kaerus Bioscience upfront, with additional development and ...